Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Institute of Human Genetics Munich, |
RCV000995765 | SCV001150100 | pathogenic | Wolcott-Rallison dysplasia | 2018-01-10 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002549918 | SCV003524700 | pathogenic | not provided | 2023-05-21 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 807600). This variant is also known as R902X and Arg902Ter. This premature translational stop signal has been observed in individual(s) with Wolcott-Rallison syndrome (PMID: 19837917, 31183082). This variant is present in population databases (no rsID available, gnomAD 0.004%). This sequence change creates a premature translational stop signal (p.Arg903*) in the EIF2AK3 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in EIF2AK3 are known to be pathogenic (PMID: 11997520). |
Baylor Genetics | RCV000995765 | SCV004194588 | pathogenic | Wolcott-Rallison dysplasia | 2023-09-12 | criteria provided, single submitter | clinical testing |